ClimateAugust 8, 2026
sigvotatug
sig-vo-tuh-TUG
Definition
An experimental antibody-drug conjugate pharmaceutical product, originally developed by Seagen, intended for the treatment of certain cancers.
Etymology
The name is a proprietary, coined pharmaceutical designation following standard drug nomenclature, constructed to be distinct for regulatory and identification purposes in oncology.
In the news
The word identifies a specific oncology drug candidate that Pfizer wrote down by $3.8 billion due to unsuccessful clinical trial results, significantly impacting the company's financial reporting.
Pfizer (NYSE:PFE) climbs 7% after main drugs offset fall in COVID sales
Read the full article ↗TechStock²